Abstract
Manidipine (MDP,(±)-2-[-(diphenylmethyl)-1-piperazinyl]ethylmethyl-1,4-dihydro-2,6-dimethyl-4(m-nitrophenyl)-3,5-pyridinedicarboxylate methyl-ester) is a poorlysoluble (<1 μg/mL) long acting antihypertensive drug. Salt formingwith citric or tartaric acid results in a 400 to 600 fold solubilityenhancement, respectively, which can be further increased by an order ofmagnitude with cyclodextrins. Dimethyl-βCD alone results in a more than8000 fold solubility enhancement. Besides the strongly enhanced solubility1HNMR spectroscopy also proves the inclusion-type interactionbetween Manidipine and cyclodextrins. From the attained 5-8 mg/mL solubilityof the drug in water an improved bioavailability and pharmacokinetics isexpected.
Similar content being viewed by others
References
Takeda Chemical Industries Ltd., European Pat. n. 94159 B1, 1983.
O. Iimura and K. Shimamoto: Am. Heart. J. 125, 635 (1993).
D. M. Abernethy and J. B. Schwartz: Clin. Pharmacokinet. 15, 1 (1988).
B. W. Müller and E. Albers: Int. J. Pharm. 79, 273 (1992).
P. Chiesi, P. Ventura, M. Pasini, E. Redenti, J. Szejtli, M. Vikmon: Highly solublemulticomponent complexes containing a basetype drug, an acid and a cyclodextrin, PCT Int. Pat. Appl. WO 94/16733 (1994).
G. Wenz and E. Von der Bey: in O. Huber and J. Szejtli (eds.),Proceedings of the 4th International Symposium on Cyclodextrins; Kluwer, Dordrecht, 1988, pp. 133–138.
SigmaplotR, Version 4.0; Jandel Scientific Co., California.
K. Connors in Cyclodextrins vol. 3., in J. L. Atwood, J. E. D. Davies, D. D. MacNicol and F. Vögtle (eds.), Comprehensive Supramolecular Chemistry, Pergamon Press: Oxford, 1996; pp. 205–241.
T. Higuchi and K. A. Connors: Advan. Anal. Chem. Instr. 4, 117 (1969).
M. Vikmon, J. Szemán, J. Szejtli, M. Pasini, E. Redenti and P. Ventura: in Proceedings of the 7th International Cyclodextrins Symposium, Publ. Office Acad. Soc. Japan, Tokyo, 1994; pp. 480–483.
L. Szente, J. Szejtli, M. Vikmon, J. Szemán, E. Fenyvesi, M. Pasini, E. Redenti, P. Ventura: in Proceedings of the 1st World Meeting on Pharmaceutics, Biopharmaceutics, Pharmaceutical Technology, APGI/APV: Budapest, 1996 pp. 579–580.
M. T. Esclusa Diaz, M. B. Perez Marcos, J. L. Vila Lato, J. Torres Labandeira in Proceedings of the 8th International Symposium on Cyclodextrins, Budapest, Kluwer, Dordrecht, 1996, pp. 305–308.
Cyclodextrin News, Volume 7. No. 8., April, pp. 331–332 (1993).
F. Djedaini, S. Z. Lin, B. Perly, D. Wouessidjewe: J. Pharm. Sci. 79, 643 (1990).
G. Fronza, A. Mele, E. Redenti, P. Ventura: J. Pharm. Sci. 81, 1162 (1992).
E. Redenti, M. Pasini, P. Ventura, A. Spisni, M. Vikmon, J. Szejtli: J. Incl. Phenom. 15, 28 (1993).
Y. Kotake and E. G. Janzen: J. Am. Chem. Soc. 111, 2067 (1989).
A. F. Casy, A. D. Cooper, T. M. Jefferies, R. M. Gaskell, D. Greatbanks, R. Pickford: J. Pharm. Biomed. Anal. 9, 787 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Csabai, K., Vikmon, M., Szejtli, J. et al. Complexation of Manidipine with Cyclodextrins and their Derivatives. Journal of Inclusion Phenomena 31, 169–178 (1998). https://doi.org/10.1023/A:1007959417684
Issue Date:
DOI: https://doi.org/10.1023/A:1007959417684